Belfast Telegraph

Friday 18 April 2014

Drugs research boost to Britain

Drug group AstraZeneca said plans for a new research base in Cambridge will boost the chances of Britain discovering the next generation of medicines. The group revealed yesterday it will build a £330m research and development site on Cambridge Biomedical Campus by 2016, employing about 2,000 staff.

Drug group AstraZeneca said plans for a new research base in Cambridge will boost the chances of Britain discovering the next generation of medicines. The group revealed yesterday it will build a £330m research and development site on Cambridge Biomedical Campus by 2016, employing about 2,000 staff.